Cd40 Ligand (cd154) Is Elevated In Fibrotic Lung Diseases, But Does Not Predict Severity

被引：0
|
作者：
Salibi, R. [1 ]
Kottmann, R. M. [1 ]
Porter, E. [1 ]
Phipps, R. [1 ]
Sime, P. J. [1 ]
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3372
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Does soluble CD154 (CD40 ligand) promote elicited anti-pig IgG antibodies in xenograft recipients?
    Ezzelarab, Mohamed
    Isse, Kumiko
    Ekser, Burcin
    Iwase, Hayato
    Morelli, Adrian
    Ayares, David
    Cooper, David K. C.
    XENOTRANSPLANTATION, 2013, 20 (05) : 340 - 341
  • [42] CD40L(CD154)及CD40研究进展
    李佐青
    细胞与分子免疫学杂志, 2004, (03) : 381 - 384
  • [43] Cutting edge: Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization
    Mendoza, RB
    Cantwell, MJ
    Kipps, TJ
    JOURNAL OF IMMUNOLOGY, 1997, 159 (12): : 5777 - 5781
  • [44] CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines
    Kornbluth, RS
    Kee, K
    Richman, DD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) : 5205 - 5210
  • [45] CD40 ligand (CD154) stimulates macrophages to produce HIV-suppressive β-chemokines.
    Kornbluth, RS
    Kee, K
    Richman, DD
    FASEB JOURNAL, 1998, 12 (05): : A925 - A925
  • [46] Abnormal CD40 ligand (CD154) expression in human immunodeficiency virus-infected children
    O'Gorman, MRG
    DuChateau, B
    Paniagua, M
    Hunt, P
    Bensen, N
    Yogev, R
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (06) : 1104 - 1109
  • [47] Elevated CD154 (CD40 ligand) synthesis in T-cells from allergic patients after nonspecific stimulation in vitro
    Markert, UR
    Bär, C
    Niess, JH
    Vogelsang, H
    Zwacka, G
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 1999, 9 (04): : 248 - 252
  • [48] Characterization of the required CD40L(CD154)/CD40 interaction in MAIDS.
    Green, KA
    Noelle, RJ
    Green, WR
    FASEB JOURNAL, 1999, 13 (05): : A971 - A971
  • [49] Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges
    Law, Che-Leung
    Grewal, Iqbal S.
    THERAPEUTIC TARGETS OF THE TNF SUPERFAMILY, 2009, 647 : 8 - 36
  • [50] CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes
    Larkin, R
    Benjamin, CD
    Hsu, YM
    Li, Q
    Zukowski, L
    Silver, RF
    INFECTION AND IMMUNITY, 2002, 70 (08) : 4716 - 4720
12345